UK-based Darktrace's stock falls 32.47% after US private equity firm Thoma Bravo ends bid interest in the scandal-hit AI and cybersecurity company
Rob Davies / The Guardian :
Context & Ripple Effects
Darktrace entered public markets with a strong first day of London trading after an IPO that raised £165.1M, leaving its valuation particularly exposed to shifts in takeover expectations. Thoma Bravo had already established itself as a buyer of UK cybersecurity assets through its £3.1B Sophos acquisition.
The withdrawn approach was not the end of the relationship: related coverage later records Thoma Bravo's agreement to buy Darktrace in 2024. That makes the 2022 sell-off evidence of how sharply a prospective buyer's interest can shape the company's public-market price.
First-order effects
- Darktrace shareholders immediately lose the takeover premium implied by Thoma Bravo's pursuit, as reflected in the 32.47% share-price fall.
- Thoma Bravo exits the active pursuit of Darktrace, while Darktrace must again be valued by investors without a live private-equity bid.
Second-order effects
- The sell-off resets the bargaining position for any future buyer: Darktrace's market price, rather than the abandoned approach, becomes the reference point for renewed negotiations.
- Darktrace's public investors face greater sensitivity to operational and governance developments after the bid-based valuation support disappears.
Third-order effects
- The later 2024 agreement suggests private-equity interest in cybersecurity can be cyclical rather than final, with public-market volatility creating opportunities for buyers to revisit targets.
- If this pattern persists, listed cybersecurity companies with strategic buyers in the background will trade increasingly on the durability and timing of buyout interest, not solely on standalone performance.
The trend: Cybersecurity is becoming a recurring private-equity target category, with public valuations moving sharply as prospective buyers enter and leave the process.